Drug Profile
Malaria vaccine - The Jenner Institute
Latest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator The Jenner Institute
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for phase-I development in Malaria in United Kingdom
- 03 Nov 2015 Phase-I clinical trials in Malaria in United Kingdom (unspecified route)